Services Startup-Centred Regulatory Support

The Regulatory Catalyst

Transparent, value-driven service packages that deliver expert regulatory guidance to startups looking to attract investors while accelerating market entry. With maximum impact, and no hidden costs.

The Regulatory Catalyst - value-driven regulatory packages for startups

DLRC are proven specialists in global product development and regulatory affairs. With offices in the UK, US and EU, our team has guided numerous startups from pre-clinical to market success.

Unlocking the benefits of regulatory clarity for startups

The Regulatory Catalyst

Whatever your objective, challenge, or situation, we can help:

Ready to catalyse your journey to market?

Find out how The Regulatory Catalyst can help you attract investors and accelerate your market entry.

Case study

Take a look at how we have helped one of our clients.

First-in-Class Orphan Drug Approval Leads to Multi-Billion-Dollar Acquisition

Challenge

A European biotech company needed comprehensive regulatory support for their ground breaking orphan drug targeting a rare viral condition. Without an in-house regulatory department, they required end-to-end expertise from clinical development through market approval.

Solution

DLRC stepped in as a complete virtual regulatory department, providing:

  • Strategic regulatory guidance and program management
  • Leadership for all regulatory agency interactions
  • Expert document preparation and management
  • Full eCTD publishing services

 

Our team delivered critical support across multiple regulatory milestones, including:

  • Scientific Advice meetings
  • Orphan Drug Designation (ODD) maintenance
  • Pediatric Investigation Plan (PIP)
  • Clinical Trial Applications (CTAs)
  • Marketing Authorisation Application (MAA)

 

Despite the complexities of a first-in-class therapy, our team ensured the MAA submission met all deadlines and and followed an accelerated timetable

Outcome

The product was approved in the EU, validating the therapy’s value and DLRC’s regulatory strategy. This approval was a key factor in the Sponsor’s subsequent acquisition in a multi-billion-dollar deal. DLRC continued to support the new sponsor with preparations for the Biologics License Application (BLA).

When the CEO launched a new company, they engaged DLRC to manage all aspects of regulatory affairs for their ongoing development project. This continuous collaboration showcases how strategic regulatory expertise can deliver substantial value throughout the drug development lifecycle, from initial clinical studies to approval and commercial success.

Stay Informed

Sign up to our bimonthly newsletter for the latest news and industry insights

    Please check this box to submit the form and agree to communications from DLRC and the storage and handling of your data, in accordance with our Privacy Policy.

    Thank you for your submission.